ICMR

Potential stemness genes knockout through CRISPR- Cas9 technology in triple-negative breast cancer cells via multitalented nano-hybrids. Experience in CRISPR-Cas9 gene editing system, Animal cell culture, RT-PCR, In vivo, Animal handling, Nanoparticle synthesis and characterization, SELEX technique. Willingness to enroll in the PhD programm at ARI. Post Graduate in Biotechnology/ Life Science. 

Postgraduate degree including the integrated PG degree in any branch of Life Sciences - Biological Sciences, Biotechnology, Biochemistry, Genetics.

Graduate of minimum three years duration in pharmacy with three years experience in pharmacy OR Post graduate degree in Pharmacy. Neonatal and or Pediatric Nursing experience, Working Knowledge of Data Entry in the computers Experience in drug preparation in clinical research study preferably involving children or neonates.

Candidates with research experience in tumor immunology, cancer biology with a proven hand in animal handling, animal animal-related experiments as evident from the original research publications will be preferred.

Adult stem cell derived exosomes, A cell-free therapy for glaucoma. Experience in animal models for evaluating preclinical safety, pharmacokinetics and efficacy will be preferable. Candidates with GPAT or equivalent exams will be given a preference. Candidate must be interested in learning new concepts, tools, and techniques. 

In vitro and in vivo evaluation of liposome encapsulated Mycobacteriophages D29 and TM4 as therapeutic candidates against Mycobacterium tuberculosis. The candidate must have First class post graduate degrees or second class post graduate with PhD degree in relevance to nano technology, nano-delivery, biological therapeutics, pharmaceutical sciences, Biotechnology, Desirable experience: PhD thesis submitted or having Research fellow experience or having previous experience in nano/liposomal formulation, stability and characterization. PG degrees in Microbiology / Biotechnology / Biomedical Science, with three years experience or PhD in Microbiology / Biotechnology / Biomedical Science

Establishment of a centre for advanced research on developing novel inhibitors that target the protein translation machinery of malaria parasite. A Scientist with expertise in chemical library screening, synthetic chemistry, and medicinal chemistry to develop next-generation antimalarial therapies. You will design and synthesize novel compounds, screen chemical libraries for potential drug candidates, and optimize lead molecules for efficacy and safety.

The candidate should be a Registered Technology Transfer Professional RTTP, with demonstrated experience in the profession of Technology Management so as to create efficient systems for enabling technology transfers.  Masters with PhD from a recognized University in any of the following subjects Biotechnology, Microbiology, Genetics, Medical Genetics, Immunology.

National Survey for Community Perspective Assessment and Preventive Strategies for Malaria Control in Selected Malaria Endemic States, India. Liaisoning with the state officials, private health facilities. Project implementation, data collection at study sites.